Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery

New England Journal of Medicine

Volumn 337, Issue 22, 1997, Pages 1569-1575

  Bigger Jr , J Thomas ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATOR; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ARRHYTHMIA; CORONARY ARTERY BYPASS; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030726341     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199711273372201     Document Type: Article

References (39)

1. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-4.
2. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13:1353-61.
3. Nisam S, Kaye SA, Mower MM, Hull M. AICD automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients. Pacing Clin Electrophysiol 1995;18:142-7
4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
5. Eisenberg MS, Pantridge JF, Cobb LA, Geddes LS. The revolution and evolution of prehospital cardiac care. Arch Intern Med 1996;156:1611-9.
6. Lombardi G, Gallagher J, Gennis P. Outcome of out-of-hospital cardiac arrest in New York City: the Pre-Hospital Arrest Survival Evaluation (PHASE) Study. JAMA 1994;271:678-83.
7. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA 1993;270:1589-95.
8. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
9. Holmes DR Jr, Davis KB, Mock MB, et al. The effect of medical and surgical therapy on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation 1986;73:1254-63.
10. Varnauskas E, European Coronary Surgery Study Group. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery. Circulation 1985;72:Suppl V:V-90-V-101.
11. The CABG Patch Trial Investigators and Coordinators. The Coronary Artery Bypass Graft (CABG) Patch Trial. Prog Cardiovasc Dis 1993;36:97-114.
12. Gottlieb CD, Bigger JT Jr, Steinman RC, Rolnitzky LM. Signal averaged ECG predicts death after CABG surgery. Circulation 1995;92:Suppl I:I-406. abstract.
13. Curtis AB, Cannom DS, Bigger JT Jr, et al. Baseline characteristics of patients in the Coronary Artery Bypass Graft (CABG) Patch Trial. Am Heart J (in press).
14. Bigger JT Jr, Parides MK, Meier P, Levin B, Rolnitzky LM. Changes in sample size and length of follow-up to maintain power in the CABG Patch Trial. Control Clin Trials (in press).
15. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
16. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The early termination of clinical trials: causes, consequences, and control: with special reference to trials in the field of arrhythmias and sudden death. Circulation 1994;89:2892-907.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
19. Baum RS, Alvarez H III, Cobb LA. Survival after resuscitations from out-of-hospital ventricular fibrillation. Circulation 1974;50:1231-5.
20. Bayes de Luna A, Coumel PH, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmias on the basis of data from 157 cases. Am Heart J 1989;117:151-9.
21. Bigger JT Jr, Fleiss JL, Kleiger RE, Miller JP, Rolnitzky LM, Multi-center Post-Infarction Research Group. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250-8.
22. Mukharji J, Rude RE, Poole WK, et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol 1984; 54:31-6.
23. Ahnve S, Gilpin E, Henning H, Curtis G, Collins D, Ross J Jr. Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction Am J Cardiol 1986;58:872-8. [Erratum, Am J Cardiol 1987;59:A12.]
24. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation 1985;72:681-5.
25. Bigger JT Jr. Why patients with congestive heart failure die: arrhythmias and sudden cardiac death. Circulation 1987;75:Suppl IV:IV-28-IV-35.
26. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
27. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
28. Steinberg JS, Regan A, Sciacca RR, Bigger JT Jr, Fleiss JL. Predicting arrhythmic events after myocardial infarction using the signal-averaged electrocardiogram. Am J Cardiol 1992;69:13-21.
29. el-Sherif N, Denes P, Katz R, et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period: the Cardiac Arrhythmia Suppression Trial/Signal-Averaged Electrocardiogram (CAST/SAECG) Substudy Investigators. J Am Coll Cardiol 1995;25:908-14.
30. Signal-averaged electrocardiography. J Am Coll Cardiol 1996;27:238-49.
31. O'Rourke RA. Role of myocardial revascularization in sudden cardiac death. Circulation 1992:85:Suppl I:I-112-I-117.
32. Kelly P, Ruskin JN, Vlahakes GJ, Buckley MJ Jr, Freeman CS, Garan H. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 1990;15:267-73.
33. Kron IL, Lerman BB, Haines DE, Flanagan TL, DiMarco JP. Coronary artery bypass grafting in patients with ventricular fibrillation. Ann Thorac Surg 1989;48:85-9.
34. Every NR, Fahrenbruch CE, Hallstrom AP, Weaver WD, Cobb LA. Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol 1992;19:1435-9.
35. Levine JH, Mellits ED, Baumgardner RA, et al. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation 1991;84:558-66.
36. Marcus FI, Cobb LA, Edwards JE, et al. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am J Cardiol 1988;61:8-15.
37. Greene HL, Richardson DW, Barker AH, et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989;63:1-6.
38. Amiodarone Trials Meta-Analysis Investigators. The effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure. Lancet 1997;350:1417-24.
39. Pitt B. The role of β-adrenergic blocking agents in preventing sudden cardiac death. Circulation 1992;85:Suppl I:I-107-I-111.